Hetty Carraway
@carrawayhetty
Director of Leukemia Program, Vice Chair of Strategy and Enterprise Development at Taussig Cancer Institute @ClevelandClinic Tweets Are Mine.
ID: 3168040672
http://my.clevelandclinic.org/staff_directory/staff_display?doctorid=18591 15-04-2015 03:02:01
7,7K Tweet
3,3K Takipçi
4,4K Takip Edilen
Our analysis of intensive chemo (IC) in CBF-AML (200 pt) is out in eJHaem Journal! Kudos to lead author Alexandra Rojek We found: -similar EFS/OS betw IC + GO & IC alone -longer 3y EFS w/ IC + KIT inhibitor (85%) we eagerly await NCT02013648 results! onlinelibrary.wiley.com/doi/10.1002/jh…
Finally out ➡️ A huge shout out for Mark Litzow ECOG-ACRIN Cancer Research Group Mayo Clinic Comprehensive Cancer Center Blinatumomab for MRD-Negative Acute Lymphoblastic Leukemia in Adults | New England Journal of Medicine nejm.org/doi/full/10.10… ➡️ consolidation Blina improves OS in MRD-ve Ph-ve B-cell ALL
Excited to kick off the 33 annual Mayo Clinic Florida #Hematology/#Oncology Reviews 2024 Mayo Clinic Comprehensive Cancer Center. Comprehensive conference that focuses on application of new clinical & #Research advancement in Hematology & #CancerCare over the last year. 👇🏼 ce.mayo.edu/hematology-and…
The Department of Radiation Oncology is very proud and honored that three of our main campus #radonc faculty Neil Woody Ehsan H. Balagamwala Jacob Miller graduated from Cleveland Clinic Lerner College of Medicine! They fully embrace the mission, values & vision of Cleveland Clinic MD. #CleClinicCancer
#Hematology: w/ Pallawi Torka we discuss the current SoC/landscape for #Follicular + #MantleCell #Lymphoma Full discussion: - cancernetwork.com/treatment-algo… - oncbrothers.com/lowgradelympho… - Also on “Oncology Brothers” podcast #HemeTwitter #MedTwitter #OncTwitter CancerNetwork® #lymsm
Pallawi Torka, MD, joins the Oncology Brothers to discuss patient workup and treatment practices in follicular lymphoma, highlighting the PRIMA study and the role of maintenance therapy. #lymsm | Pallawi Torka Oncology Brothers cancernetwork.com/view/treatment…
Congratulations to the authors 4 finally putting this decade-long ❓ to rest. Nature Medicine We can all sleep better (or worse 😬) tonight, knowing CH causes atherosclerosis & not the other way around. That’s some pretty “determinate” potential, I’d say 😉 TET2> DNMT3A & of
👉Superb review article by Prof .Nitin Jain et al on CLL in the The Lancet Aug 2024 Chronic lymphocytic leukaemia - The Lancet thelancet.com/journals/lance… | #leusm #endcancer Bill Wierda, MD, PhD MD Anderson Cancer Center Heme Reports
Updates on the Management of Acute Myeloid Leukemia mdpi.com/1857832 #mdpicancers via Cancers MDPI #AML #leusm
📣Excited to join the Oncology Brothers, great colleagues & experts, Charu Aggarwal, MD, MPH, FASCO Narjust Florez, MD, FASCO Jarushka Naidoo Dr. Estela Rodriguez Eric K. Singhi, MD on this EDUCATIONAL event during #WCLC24 on latest #Advancements in #LungCancer Tx. 📆 Sun 9/8/24 at 6 PM Join & Register👉 bit.ly/AIOWCLC24
Study Finds Immunotherapy Increases Three-Year Survival in Adults with B-Cell Precursor Acute Lymphoblastic Leukemia consultqd.clevelandclinic.org/study-finds-im… via @clevelandclinic Hetty Carraway
Ready for VeloSano ? Thank you for the leadership of Dale Shepard MD, PhD ChrisCNP (she/her) 🌈💉💊🩺🩹🩸 !! Thank you for the support of cancer research Cleveland Clinic
Our own leaders, doctors and researchers Betty Ky Hamilton Rabi Hanna Dale Shepard MD, PhD Hetty Carraway leading the way!! Thank you !! VeloSano Cleveland Clinic MD Cleveland Clinic
John Groarke was my first #CardioOnc fellow at Brigham and Women's Hospital & Dana-Farber! Now senior director at Pfizer Inc.! Congrats on leading this outstanding NEJM study on cancer cachexia! Also fascinating history of GDF15, first discovered a macrophage inhibitory factor (& called MIC1)!
